Back to top

Eli Lilly & Co: (NYSE: LLY)

(U.S: NYSE) As of Jul 22, 2014 04:00 PM ET

 Add to portfolio

 ZacksTrade Now

$63.72 USD

63.72

+0.08 (0.13%)

Volume: 3,101,757

Zacks Rank : 3-Hold [?]     3    

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.65%
2 Buy 18.84%
3 Hold 10.45%
4 Sell 4.76%
5 Strong Sell 2.56%
S&P 500 10.28%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

Industry / Sector Report

Industry: LARGE CAP PHARMA

Zacks Industry Rank: 91 / 265 (Top 34.34%)

Rank in Industry:

Premium Research: Industry Analysis

Top Peers Symbol Zacks Rank
LILLY ELI & CO LLY
ALLERGAN INC AGN
ABBOTT LABS ABT
ABBVIE INC ABBV
ASTRAZENECA PLC AZN
PFIZER INC PFE
BAYER A G -ADR BAYRY
BRISTOL-MYERS BMY
GLAXOSMITHKLINE GSK
JOHNSON & JOHNS JNJ

Recommendations and Estimates

Company Industry SP500
Average Recommendation (1=Buy, 5=Sell) 2.38 2.06 9.99
Current Quarter Estimate 0.66 22.83 -999.00
Year Ago Quarter Estimate 1.16 19.74 26.36
Next Quarter Estimate 0.69 23.27 -999.00
Next Year Estimate 3.13 19.58 26.92

Growth Rates

Company Industry SP500
This Year (-32.9) -32.90 0.90 9.00
Next Year (12.5) 12.50 10.70 6.80
Last 5 Years 0.80 4.00 11.20
Next 5 Years 5.00 6.40 NA

Financials

Company Industry
Price/Earnings (TTM) 17.15 26.37
Price/Book (MRQ) 3.88 3.89
Price/Cash Flow (MRFY) 12.05 12.92
Dividend Yield 3.08% 2.65%
Net Profit Margin (TTM) 17.41% 16.72%
Return on Equity (TTM) 23.51% 17.42%
Debt to Equity (MRQ) NA 15.44

MRQ = Most Recent Quarter

TTM = Trailing Twelve Months

MRFY = Most Recent Fiscal Year

Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.